This article covers validating a claim bundle before it goes anywhere for Indian clinics and hospitals. Every figure, payer behaviour and regulatory reference below is Indian — nothing here is adapted from a US or UK playbook.
What this looks like in an Indian practice
The mechanics differ here in ways that imported software does not model. Indian payer contracts, scheme package rates and clinical vocabulary all behave differently from the assumptions built into products designed for other markets.
Drapto is built to international engineering standards and sold exclusively in India for now, precisely so these details are modelled rather than approximated.
Where the money goes
Leakage in Indian practices is rarely one large event. It is a repeated small deduction, an uncollected balance, or a claim that converts from cashless to reimbursement because a clock ran out.
Each of those is measurable. None of them shows up in a day book.
What to measure
Start with a number you can produce this week from records you already have, then instrument the process rather than the outcome.
A metric nobody can compute from existing data is a metric nobody will maintain.
Questions we get asked
Is this specific to India?
Yes. Drapto is engineered to international standards and sold exclusively in India for now, so payer mechanics, scheme rates and clinical vocabulary are modelled for Indian practice rather than adapted from another market.
Does this apply to a single clinic or a hospital?
The abdm, nhcx & compliance cluster covers both, with the differences called out where they matter.
Built to international standards. Sold in India only, for now.
Drapto is engineered the way any serious international health platform is — FHIR R4, audit trails, self-hosting — and sold exclusively to Indian clinics and hospitals, so the payer mechanics, scheme rates and clinical vocabulary are modelled rather than approximated.